Concepedia

Publication | Open Access

Evaluation of lecithinized human recombinant super oxide dismutase as cardioprotectant in anthracycline‐treated breast cancer patients

DOIFull Paper Access

29

Citations

38

References

2014

Year

F. J. F. Broeyer, Susanne Osanto, Jun Suzuki, Felix de Jongh, H. van Slooten, Bea C. Tanis, Tobias A. Bruning, Jeroen J. Bax, Henk J. Ritsema van Eck, Marieke L. de Kam,
British Journal of Clinical Pharmacology

Abstract

PC-SOD at a dose of 80 mg i.v. is not cardioprotective in patients with breast carcinoma treated with anthracyclines.

References

YearCitations

Page 1